EMA to review ALK's registration application for house dust mite tablet
European health authorities have accepted an application to review a tablet treatment of house dust allergy in young children developed by Danish vaccine maker ALK.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.